US Stock MarketDetailed Quotes

DRIO DarioHealth

Watchlist
  • 1.530
  • +0.678+79.58%
Close Jan 7 16:00 ET
  • 1.200
  • -0.330-21.57%
Pre 09:11 ET
52.17MMarket Cap-1.65P/E (TTM)
Pre-Market
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Comments

    Jaguar8
    Jaguar8
    Nov 21, 2024 07:34
    NEWS
    $DarioHealth (DRIO.US)$
    Dario Signs Four New Employer Contracts Across Full Product Suite
    DarioHealth (Nasdaq: DRIO) has secured four new self-insured employer contracts, expected to go live in Q1 2025. These contracts cover Dario's complete platform suite, with clients opting for multi-condition offerings rather than single-condition solutions. The company projects to achieve approximately 25 new client signings in 2024, representing a 35% growth in client base compared to 2023.
    These new ...
    Jaguar8
    Jaguar8
    Sep 10, 2024 07:32
    NEWS
    $DarioHealth (DRIO.US)$
    Dario Publishes New Research Revealing How Physical Activity Mediates the Impact of Depression on Blood Glucose Levels in Individuals with Diabetes or Prediabetes
    DarioHealth Corp. (Nasdaq: DRIO) has published a new study in Frontiers in Endocrinology, demonstrating the effectiveness of its cardiometabolic solution for individuals with diabetes or prediabetes and depression. The research, involving 989 users over 12 months, reveals:
    Members with depression showed highe...
    Trytosaveabit
    Trytosaveabit
    Jul 16, 2024 07:32
    Update
    $DarioHealth (DRIO.US)$ Reuters· just
    DarioHealth-New Contract With National Employer to Provide Cardiometabolic Solution With Integrated Support for Glp-1S to Employees Beginning in Q3
    Jaguar8
    Jaguar8
    Jun 25, 2024 07:30
    NEWS
    $DarioHealth (DRIO.US)$
    Dario Demonstrates 12 Months of Sustained Healthy Behavior Change for Members Taking a GLP-1
    New research presented by DarioHealth at the 84th Annual ADA Scientific Sessions demonstrates the efficacy of their digital health platform in sustaining behavior change for members taking GLP-1 medications. Data over a 12-month period show significant improvements in healthy lifestyle tracking and blood glucose control. Notably, 31% of Type 2 diabetes members achieved results ...
Read more
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-1.24%